Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Evolent Health Shares Jumped Today

By Brian Orelli, PhD - May 8, 2020 at 12:46PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This healthcare company appears to be pretty healthy.

What happened

Shares of Evolent Health (EVH -2.59%) were up 7.6% at 1:12 p.m. EDT on Friday following the release of first-quarter results after the closing bell on Thursday. The healthcare company, which provides clinical and administrative solutions to health insurers and other payers, basically met its revenue goal for the quarter and kept its 2020 revenue guidance the same. But in this market, that's quite the achievement, and investors are valuing the company accordingly.

So what

Evolent Health was able to increase revenue by 25% year over year to $247.3 million in the first quarter. The company added two new health plans to its list of customers: EmblemHealth and an unnamed regional not-for-profit plan based in the Northeast.

COVID-19, the disease caused by the novel coronavirus, doesn't seem to be hurting the company. In fact, Evolent Health is assisting in the response by helping its customers identify members at high risk if they were infected and sending them information to limit the effects of the virus, hopefully saving lives (and money for its customers) in the process.

Evolent Health is still losing money: $77.8 million in the first quarter, which was larger than the $46.7 million loss in the year-ago quarter. But with the revenue growth this year, management thinks it can be cash flow positive by this fall.

Doctor listening to a patient's chest with a stethoscope

Image source: Getty Images.

Now what

For the year, management is still guiding for revenue of $935 million to $985 million with revenue in the second quarter expected to be in the $236 million to $247 million range. Again, that's nothing to be too excited about growth-wise. But considering that on Thursday, shares were down 23% year to date -- and trading at less than half the 52-week high -- it's understandable that investors are buying shares today in a company that appears to have been knocked down for no good reason.

Brian Orelli and The Motley Fool have no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Evolent Health, Inc. Stock Quote
Evolent Health, Inc.
$34.93 (-2.59%) $0.93

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.